Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Development of the Oral Microbiota01:28

Development of the Oral Microbiota

48
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
48
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

66
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
66
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

775
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
775
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

2
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
2
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

4
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
4
Development of Human Microbiota01:30

Development of Human Microbiota

54
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
54

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

European Consensus Guidelines on the Management of Respiratory Distress Syndrome: 2025.

Neonatology·2026
Same author

The role of Ureaplasma in preterm lung disease: does species matter?

Pediatric research·2026
Same author

The Future of Neonatal Medicine: Reducing Global Neonatal Mortality Is A Matter of Political Will - A Commentary on The Lancet Child & Adolescent Health Commission on the Future of Neonatology.

Neonatology·2025
Same author

Neonatal central nervous system infection by Ureaplasma species is rare, but relevant: results from a multicenter nationwide surveillance study.

Infection·2025
Same author

Oxygenation of Immature Infants in the Delivery Room and Beyond: A Quest for Future Research.

Neonatology·2024
Same author

Inborn Errors of Immunity in Early Childhood: Essential Insights for the Neonatologist.

Neonatology·2024
Same journal

High versus low PEEP in the delivery room: a preimplementation and postimplementation cohort study.

Archives of disease in childhood. Fetal and neonatal edition·2026
Same journal

Trends in the incidence of low-grade intraventricular haemorrhage among preterm babies: a national cohort study.

Archives of disease in childhood. Fetal and neonatal edition·2026
Same journal

Apnoeic oxygenation with nasal high flow during neonatal intubation: a prospective audit.

Archives of disease in childhood. Fetal and neonatal edition·2026
Same journal

Visual acuity assessments at 5 years in a national cohort (EPIPAGE-2).

Archives of disease in childhood. Fetal and neonatal edition·2026
Same journal

Clinicians' attitudes to the West Midlands damage control surgery pathway for severe necrotising enterocolitis.

Archives of disease in childhood. Fetal and neonatal edition·2026
Same journal

Continuous glucose monitoring in neonates at risk of hypoglycaemia: a feasibility study.

Archives of disease in childhood. Fetal and neonatal edition·2026
See all related articles

Related Experiment Video

Updated: Apr 20, 2026

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

7.1K

Late-onset neonatal sepsis: recent developments.

Ying Dong1, Christian P Speer2

  • 1Department of Paediatrics, Children's Hospital of Fudan University, Shanghai, China.

Archives of Disease in Childhood. Fetal and Neonatal Edition
|November 27, 2014
PubMed
Summary
This summary is machine-generated.

Neonatal late-onset sepsis (LOS) affects hospitalized newborns, with risks varying by maturity and location. Strategies like hygiene and minimizing invasive procedures are key to reducing LOS burden.

Keywords:
Infectious DiseasesMicrobiologyNeonatology

More Related Videos

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
14:54

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis

Published on: January 27, 2019

12.0K
A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

596

Related Experiment Videos

Last Updated: Apr 20, 2026

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

7.1K
A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
14:54

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis

Published on: January 27, 2019

12.0K
A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

596

Area of Science:

  • Neonatology
  • Infectious Diseases
  • Public Health

Background:

  • Neonatal late-onset sepsis (LOS) incidence varies geographically and by infant maturity.
  • Coagulase-negative staphylococci, Gram-negative bacilli, and fungi are primary LOS pathogens in very low birth weight infants.
  • Prompt LOS diagnosis is challenging, leading to empirical antibiotic use, often with broad-spectrum agents.

Purpose of the Study:

  • To review the epidemiology and management of neonatal late-onset sepsis (LOS).
  • To highlight concerns regarding multidrug-resistant organisms in neonatal intensive care units (NICUs).
  • To discuss current evidence on prevention strategies for neonatal LOS.

Main Methods:

  • Literature review of epidemiological data on neonatal LOS.
  • Analysis of common pathogens and treatment challenges.
  • Evaluation of current prevention strategies in NICUs.

Main Results:

  • LOS incidence is inversely related to gestational age and shows significant geographical variation.
  • Empirical antibiotic treatment for suspected LOS is common but frequently involves overuse of broad-spectrum antibiotics.
  • Multidrug-resistant Gram-negative microorganisms pose a growing threat in NICUs.

Conclusions:

  • Effective surveillance and appropriate treatment regimens are crucial for combating multidrug-resistant organisms in neonatal sepsis.
  • Immunological prevention strategies lack evidence; strict hygiene and minimizing invasive procedures are essential for reducing LOS.
  • Optimizing antibiotic stewardship and implementing robust infection control measures are vital in NICUs.